|
Sep 26
|
We Think RenovoRx (NASDAQ:RNXT) Needs To Drive Business Growth Carefully
|
|
Jun 26
|
University of Nebraska Medical Center Launches Patient Enrollment for RenovoRx’s Pivotal Phase III TIGeR-PaC Clinical Trial
|
|
Apr 16
|
RenovoRx Highlights Recent Presentation of Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
|
|
Apr 15
|
RenovoRx Closes $11.1 Million Private Placement, Providing Cash Runway into 2026
|
|
Feb 6
|
RenovoRx CEO Issues Letter to Shareholders
|
|
Jan 29
|
RenovoRx Closes $6.1 Million Private Placement
|
|
Dec 21
|
RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
|
|
Dec 19
|
RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
|